cover
Contact Name
Ni Made Dharma Shantini Suena
Contact Email
vrndaranyadasi@gmail.com
Phone
+628563740032
Journal Mail Official
medicamento@unmas.ac.id
Editorial Address
Jalan Kamboja No.11A, Denpasar Utara, Denpasar, Bali
Location
Kota denpasar,
Bali
INDONESIA
Jurnal Ilmiah Medicamento
ISSN : -     EISSN : 23564814     DOI : https://doi.org/10.36733/medicamento.v6i1
Core Subject : Health,
Jurnal Ilmiah Medicamento (JINTO) dengan nomor registrasi e-ISSN 2356-4814 didirikan pada tahun 2014, dan publikasi online dimulai pada tahun 2015. Jurnal diterbitkan dalam bahasa Indonesia. Awalnya JINTO diterbitkan oleh Akademi Farmasi Saraswati Denpasar. Namun sejak awal tahun 2019, penerbit jurnal berubah menjadi Fakultas Farmasi Universitas Mahasaraswati Denpasar karena institusi penerbit sebelumnya yaitu Akademi Farmasi Saraswati Denpasar telah mengalami penyatuan ke dalam institusi Universitas Mahasaraswati Denpasar menjadi Fakultas Farmasi. Jurnal Ilmiah Medicamento diterbitkan setiap enam bulan sekali (Maret dan September) yang berisi penelitian di bidang ilmu farmasi. JINTO menerima artikel yang mencakup berbagai bidang ilmu farmasi seperti: Farmakologi dan Toksikologi; Farmasi Klinik dan Komunitas; Kimia Farmasi; Biologi Farmasi; Teknologi Farmasi; Farmasi Mikrobiologi dan Bioteknologi; Regulatory Affairs and Pharmacy Marketing Research; Pengobatan alternatif.
Articles 332 Documents
Digitalization of HYPOGLYRISK and Evaluation of Its Utility for Pharmacist-Led Hypoglycemia Risk Assessment in Type 2 Diabetes Mellitus Jaya, Made Krisna Adi; Ikawati, Zullies; Rahmawati, Fita; Yasin, Nanang Munif; Putra, I Gusti Ngurah Anom Cahyadi
Jurnal Ilmiah Medicamento Vol 12 No 1 (2026): Jurnal Ilmiah Medicamento (In progress)
Publisher : Fakultas Farmasi Universitas Mahasaraswati Denpasar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36733/medicamento.v12i1.13619

Abstract

Background: We developed a tool for pharmacists to facilitate screening of medication-related hypoglycemia risk in patients with type 2 diabetes mellitus (T2DM), called HYPOGLYRISK. Although this instrument has been validated and proven reliable, the paper-based version was considered inefficient and prone to human error during routine screening.Objective: This study aimed to digitalize HYPOGLYRISK and evaluate its utility compared with the printed version.Methods: A mixed-method study design combining software development and a quasi-experimental trial was used. In the development stage, the application was created using Android Studio and validated through Black Box Testing and User Acceptance Testing (UAT). In the trial stage, 46 pharmacists participated and were divided into two groups using either the digital or paper-based HYPOGLYRISK to assess simulated ambulatory T2DM patients representing different hypoglycemia risk categories. The primary outcome was assessment time efficiency, while the secondary outcome was the potential for human error. Data were analyzed using the Mann-Whitney U test, chi-square test, and relative risk analysis.Results: The digital HYPOGLYRISK demonstrated significantly shorter assessment time compared with the conventional version (p<0.05) and reduced the probability of scoring errors by 3.3 times (p<0.05). The digital application also provided additional advantages, including efficiency, scalability, ease of use, rapid data access, and simplified data management.Conclusion: These findings suggest that digital HYPOGLYRISK can enhance pharmacist-led hypoglycemia risk assessment among ambulatory patients with T2DM.
Photoprotective Activities of Standardized Anredera scandens (L.) Moq. Leave Extract: an In-Vitro Study on UVB Absorption and UVA Protection Samirana, Putu Oka; Nugraha, I Gusti Agung Anom Krisna; Putra, Anak Agung Gede Rai Yadnya
Jurnal Ilmiah Medicamento Vol 12 No 1 (2026): Jurnal Ilmiah Medicamento (In progress)
Publisher : Fakultas Farmasi Universitas Mahasaraswati Denpasar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36733/medicamento.v12i1.13690

Abstract

Background: Skin cancer is a worldwide disease caused by exposure to ultraviolet radiation, both UVA and UVB rays. Interest in discovering new natural ingredients with photoprotective activity has increased research to find plants containing high amounts of phenolic and flavonoid compounds.Objective: This research aimed to assess the in vitro photoprotective activity of ASL (ethanol extract of Anredera scandens (L.) Moq. leaves) standardized based on the Indonesian Herbal Pharmacopoeia.Methods: Extraction was performed using the maceration method with 70% ethanol as the solvent. Parameters used to determine quality are drying loss, water content, total ash content, acid insoluble ash content, total flavonoid content, and total phenolic content. Photoprotective activity against UVB rays was determined by measuring SPF value using the Mansur spectrophotometric method, while activity against UVA rays was tested using the trans-resveratrol degradation model.Results: Results indicate that ASL extract fulfilled quality requirements based on total flavonoid content (9.983 ± 0.090%) and total phenolic content (13.098 ± 0.611%). The SPF value was increased proportional to the increase in concentration. The sample showed an SPF value of 5.96 when tested at a concentration of 200 µg/mL. SPF value reached 27.9 at 1,000 µg/mL. The UVA photoprotection assay indicated that the ASL extract provided limited protection against trans-resveratrol degradation, with a reduction of 18.90%, which was lower than the positive control but still significantly better than the negative control.Conclusion: ASL extract can be developed as a candidate for a natural-based photoprotective active ingredient, used as a single agent or supportive component for sunscreen products.